Form 4 for HIND Vyome Holdings, Inc
Accepted 2022-12-20 00:00:00 ET · period of report 2022-11-17 · accession 0001235802-22-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-20 | 2022-11-28+ | HIND | STANKOVICH THOMAS | CFO | S - Sale | $0.1696 | -372.1K | 327.6K | -53% | -$63.1K |
| 2022-12-20 | 2022-11-17 | HIND | STANKOVICH THOMAS | CFO | A - Grant | $0.00 | +364.8K | 697.5K | +110% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value per share | 2022-11-28 | S | D | 364,756 | $0.17 | 332,761 | D | — | — | |
| 2 | Common | Common Stock, $0.001 par value per share | 2022-11-17 | A | A | 364,756 | $0.00 | 697,517 | D | — | — | (F1) These shares were issued pursuant to a stock bonus granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan. |
| 3 | Common | Common Stock, $0.001 par value per share | 2022-12-01 | S | D | 2,213 | $0.15 | 325,404 | D | — | — | |
| 4 | Common | Common Stock, $0.001 par value per share | 2022-12-01 | S | D | 5,144 | $0.15 | 327,617 | D | — | — |